Prevalence of amyotrophic lateral sclerosis–United States, 2010-2011

At a glance

First prevalence estimate of ALS in the US conducted by the National ALS Registry

Affiliates

Paul Mehta1, Vinicius C. Antao1, Wendy Kaye2, Marchelle Sanchez1, David Williamson1, Leah Bryan3, Oleg Muravov1, Kevin Horton1

  1. Agency for Toxic Substances and Disease Registry, Division of Toxicology and Human Health Sciences
  2. McKing Consulting Corporation, Atlanta, Georgia
  3. Carter Consulting International, Atlanta, Georgia

Journal

American Journal of Public Health

Summary

This is the first population-based prevalence estimate and description of demographic characteristics of ALS for the US. Data originated from the Agency for Toxic Substances and Disease’s National ALS Registry launched in 2009. Registry findings are consistent with estimates from long-established ALS registries in Europe and from smaller-scale epidemiologic studies conducted previously in the United States.

Link to paper

Find the paper here!

Print
Content Source:
Agency for Toxic Substances and Disease Registry